CRISPRによるRNA断裂の修復は,ヒト細胞における局所性RNA切除を可能にします
Anna Nemudraia1, Artem Nemudryi1, Blake Wiedenheft1
1Department of Microbiology and Cell Biology, Montana State University, Bozeman, MT 59717, USA.
まとめ
科学者たちは新しいCRISPRRNA編集ツールを開発し 精密にRNAを切断して修復しました この技術により プログラム可能なRNAの削除により 遺伝子の機能が回復し 治療への扉が開きます
科学分野:
- 分子生物学
- 遺伝子編集技術
- RNAセラピー
背景:
- CRISPR-Casシステムは DNA編集のための強力なツールです
- 現在のCRISPR技術は RNAではなくDNAを 標的にしています
- 精密なRNA操作の方法は限られている.
研究 の 目的:
- サイト固有のRNA操作の技術を確立する.
- CRISPRを使って プログラム可能なRNAの消去を証明する
- RNA編集の治療的な応用を探求する
主な方法:
- サイト固有のRNA断裂を生成するためにCRISPR複合体を使用した.
- ヒト細胞のRNAの修復を研究した.
- CRISPR媒介のRNA修復を適用してトランスクリプトを修正する.
主要な成果:
- 人体細胞におけるCRISPRによるRNA破裂の修復が成功していることが実証された.
- 人間のトランスクリプトに プログラム可能な削除を 達成した.
- RNA編集による遺伝子の機能の回復を 示した.
結論:
- 精密なRNA操作のための新しい技術を確立しました.
- タイプIIIのCRISPR複合体はRNA編集に利用できる.
- このRNA編集アプローチは 治療的介入の可能性を秘めています
関連する概念動画
Homologous Recombination
50.5K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.5K
Nucleotide Excision Repair
3.5K
DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
3.5K
Conservative Site-specific Recombination and Phase Variation
6.0K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.0K
CRISPR
50.8K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.8K
Base Excision Repair
22.3K
One of the common DNA damages is the chemical alteration of single bases by alkylation, oxidation, or deamination. The altered bases cause mispairing and strand breakage during replication. This type of damage causes minimal change to the DNA double helix structure and can be repaired by the base excision repair (BER) pathways. BER corrects damaged DNA sequences by removing the damaged base and restoring the original base sequence using the complementary strand as a template.
The first step of...
The first step of...
22.3K
Long-patch Base Excision Repair
7.0K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.0K


